Cheyne Capital Management (UK)’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-318,008
Closed -$795K 33
2022
Q4
$795K Buy
+318,008
New +$795K 1.39% 27